Connor, Clark & Lunn Investment Management (CC&L)
CDNA icon

Connor, Clark & Lunn Investment Management (CC&L)’s CareDx CDNA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.64M Sell
268,207
-101,976
-28% -$2.22M 0.01% 613
2026
Q1 		$6.43M Sell
370,183
-294,882
-44% -$5.58M 0.01% 614
2025
Q4 		$12.5M Sell
665,065
-404,744
-38% -$6.78M 0.03% 403
2025
Q3 		$15.6M Sell
1,069,809
-12,499
-1% -$178K 0.05% 316
2025
Q2 		$21.1M Buy
1,082,308
+78,728
+8% +$1.4M 0.07% 237
2025
Q1 		$17.8M Buy
1,003,580
+128,383
+15% +$2.77M 0.08% 215
2024
Q4 		$18.7M Buy
875,197
+178,304
+26% +$4.34M 0.08% 184
2024
Q3 		$21.8M Buy
696,893
+306,222
+78% +$7.62M 0.11% 158
2024
Q2 		$6.07M Buy
390,671
+128,926
+49% +$1.56M 0.03% 385
2024
Q1 		$2.77M Buy
261,745
+93,430
+56% +$935K 0.01% 584
2023
Q4 		$2.02M Buy
168,315
+29,761
+21% +$244K 0.01% 663
2023
Q3 		$970K Sell
138,554
-54,887
-28% -$507K 0.01% 832
2023
Q2 		$1.64M Buy
193,441
+4,755
+3% +$39.6K 0.01% 659
2023
Q1 		$1.72M Buy
188,686
+75,500
+67% +$966K 0.01% 585
2022
Q4 		$1.29M Buy
113,186
+26,521
+31% +$393K 0.01% 646
2022
Q3 		$1.48M Buy
86,665
+63,497
+274% +$1.36M 0.01% 567
2022
Q2 		$498K Buy
+23,168
New +$643K ﹤0.01% 778
2021
Q3 		– Sell
-32,322
Closed -$2.96M – 1063
2021
Q2 		$2.96M Buy
32,322
+7,449
+30% +$592K 0.02% 461
2021
Q1 		$1.69M Buy
24,873
+14,065
+130% +$1.09M 0.01% 599
2020
Q4 		$783K Buy
+10,808
New +$626K ﹤0.01% 667

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CDNA Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its CareDx (CDNA) stake by 28% in Q2 2026, selling an estimated $2.22M and leaving 268,207 shares worth $7.64M. The position accounts for 0.01% of the portfolio, ranked #613.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CDNA in Q4 2020 and has held it in 20 quarters since. The position peaked at $21.8M in Q3 2024. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 268,207 shares of CareDx worth $7.64M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 101,976 CareDx shares in Q2 2026, an estimated $2.22M.
  • CareDx made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #613 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CareDx in Q4 2020 and has held it in 20 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s CareDx position peaked at $21.8M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.